Home
Browse
Search
Statistics
About
Usage
PMID: 15463882
Hubert D, Fajac I, Bienvenu T, Desmazes-Dufeu N, Ellaffi M, Dall'ava-Santucci J, Dusser D
Diagnosis of cystic fibrosis in adults with diffuse bronchiectasis.
J Cyst Fibros. 2004 Mar;3(1):15-22.,
[PubMed]
Sentences
No.
Mutations
Sentence
Comment
47
ABCC7 p.Gly551Asp
X
ABCC7 p.Gly551Asp 15463882:47:238
status:
NEW
view ABCC7 p.Gly551Asp details
ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 15463882:47:363
status:
NEW
view ABCC7 p.Arg117His details
ABCC7 p.Ala455Glu
X
ABCC7 p.Ala455Glu 15463882:47:425
status:
NEW
view ABCC7 p.Ala455Glu details
ABCC7 p.Trp1282*
X
ABCC7 p.Trp1282* 15463882:47:329
status:
NEW
view ABCC7 p.Trp1282* details
ABCC7 p.Arg553*
X
ABCC7 p.Arg553* 15463882:47:245
status:
NEW
view ABCC7 p.Arg553* details
ABCC7 p.Arg347Pro
X
ABCC7 p.Arg347Pro 15463882:47:403
status:
NEW
view ABCC7 p.Arg347Pro details
ABCC7 p.Arg347His
X
ABCC7 p.Arg347His 15463882:47:410
status:
NEW
view ABCC7 p.Arg347His details
ABCC7 p.Asn1303Lys
X
ABCC7 p.Asn1303Lys 15463882:47:432
status:
NEW
view ABCC7 p.Asn1303Lys details
ABCC7 p.Gly542*
X
ABCC7 p.Gly542* 15463882:47:231
status:
NEW
view ABCC7 p.Gly542* details
ABCC7 p.Arg1162*
X
ABCC7 p.Arg1162* 15463882:47:311
status:
NEW
view ABCC7 p.Arg1162* details
ABCC7 p.Val520Phe
X
ABCC7 p.Val520Phe 15463882:47:207
status:
NEW
view ABCC7 p.Val520Phe details
ABCC7 p.Ser549Arg
X
ABCC7 p.Ser549Arg 15463882:47:259
status:
NEW
view ABCC7 p.Ser549Arg details
ABCC7 p.Gly85Glu
X
ABCC7 p.Gly85Glu 15463882:47:440
status:
NEW
view ABCC7 p.Gly85Glu details
ABCC7 p.Tyr122*
X
ABCC7 p.Tyr122* 15463882:47:370
status:
NEW
view ABCC7 p.Tyr122* details
ABCC7 p.Arg560Thr
X
ABCC7 p.Arg560Thr 15463882:47:252
status:
NEW
view ABCC7 p.Arg560Thr details
We used an oligonucleotide ligation assay using a commercially available kit (Cystic Fibrosis Assay, Applied Biosystems, Foster City, CA, USA) to seek 31 mutations in the CFTR gene (F508del, I507del, Q943X,
V520F
, 1717y1GࡊA,
G542X
,
G551D
,
R553X
,
R560T
,
S549R
, S549 N, 3849q10kbCࡊT, 3849q4AࡊG,
R1162X
, 3659delC,
W1282X
, 3905insT, 621q1GࡊT,
R117H
,
Y122X
, 711q1GࡊT, 1078delT,
R347P
,
R347H
, R334 W,
A455E
,
N1303K
,
G85E
, 1898q1GࡊA, 2183AAࡊG, 2789q5GࡊA) which allowed to detect 82% of the CF alleles in France.
Login to comment
128
ABCC7 p.Gly551Asp
X
ABCC7 p.Gly551Asp 15463882:128:934
status:
NEW
view ABCC7 p.Gly551Asp details
ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 15463882:128:970
status:
NEW
view ABCC7 p.Arg117His details
ABCC7 p.Arg553*
X
ABCC7 p.Arg553* 15463882:128:941
status:
NEW
view ABCC7 p.Arg553* details
ABCC7 p.Asn1303Lys
X
ABCC7 p.Asn1303Lys 15463882:128:977
status:
NEW
view ABCC7 p.Asn1303Lys details
ABCC7 p.Gly542*
X
ABCC7 p.Gly542* 15463882:128:927
status:
NEW
view ABCC7 p.Gly542* details
ABCC7 p.Gly85Glu
X
ABCC7 p.Gly85Glu 15463882:128:964
status:
NEW
view ABCC7 p.Gly85Glu details
The consensus opinion is Table 3 Sensitivity of the sweat test and genotyping for the diagnosis of cystic fibrosis Positive diagnosis of CF Number of patients (percentage) Sweat test (sweat chloride)60 mmol l ) y1 37 (80%) Molecular analysis: -screening for 31 mutations 18 (39%) -complete screening 36 (78%) Combination of sweat test and molecular analysis: -sweat testqscreening for 31 mutations 42 (91%) -sweat testqcomplete screening 45 (98%) Table 4 Efficacy of the CFTR genetic analysis according to the screening method used Identified mutations Two mutations At least one mutation No mutations Screening for F508del Number of patients (%) 3 (7%) 31 (67%) 15 (33%) Screening for nine mutations* Number of patients (%) 6 (13%) 36 (78%) 10 (22%) Screening for 31 mutations** Number of patients (%) 18 (39%) 43 (93%) 3 (7%) Complete screening Number of patients (%) 36 (78%) 46 (100%) 0 Nine mutations: F508del, I507del,
G542X
,
G551D
,
R553X
, 621q1GࡊT,
G85E
,
R117H
,
N1303K
.
Login to comment
129
ABCC7 p.Gly551Asp
X
ABCC7 p.Gly551Asp 15463882:129:72
status:
NEW
view ABCC7 p.Gly551Asp details
ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 15463882:129:201
status:
NEW
view ABCC7 p.Arg117His details
ABCC7 p.Ala455Glu
X
ABCC7 p.Ala455Glu 15463882:129:263
status:
NEW
view ABCC7 p.Ala455Glu details
ABCC7 p.Trp1282*
X
ABCC7 p.Trp1282* 15463882:129:167
status:
NEW
view ABCC7 p.Trp1282* details
ABCC7 p.Arg553*
X
ABCC7 p.Arg553* 15463882:129:79
status:
NEW
view ABCC7 p.Arg553* details
ABCC7 p.Arg347Pro
X
ABCC7 p.Arg347Pro 15463882:129:241
status:
NEW
view ABCC7 p.Arg347Pro details
ABCC7 p.Arg347His
X
ABCC7 p.Arg347His 15463882:129:248
status:
NEW
view ABCC7 p.Arg347His details
ABCC7 p.Asn1303Lys
X
ABCC7 p.Asn1303Lys 15463882:129:270
status:
NEW
view ABCC7 p.Asn1303Lys details
ABCC7 p.Gly542*
X
ABCC7 p.Gly542* 15463882:129:65
status:
NEW
view ABCC7 p.Gly542* details
ABCC7 p.Arg1162*
X
ABCC7 p.Arg1162* 15463882:129:149
status:
NEW
view ABCC7 p.Arg1162* details
ABCC7 p.Gln493*
X
ABCC7 p.Gln493* 15463882:129:34
status:
NEW
view ABCC7 p.Gln493* details
ABCC7 p.Val520Phe
X
ABCC7 p.Val520Phe 15463882:129:41
status:
NEW
view ABCC7 p.Val520Phe details
ABCC7 p.Ser549Arg
X
ABCC7 p.Ser549Arg 15463882:129:93
status:
NEW
view ABCC7 p.Ser549Arg details
ABCC7 p.Gly85Glu
X
ABCC7 p.Gly85Glu 15463882:129:278
status:
NEW
view ABCC7 p.Gly85Glu details
ABCC7 p.Tyr122*
X
ABCC7 p.Tyr122* 15463882:129:208
status:
NEW
view ABCC7 p.Tyr122* details
ABCC7 p.Arg560Thr
X
ABCC7 p.Arg560Thr 15463882:129:86
status:
NEW
view ABCC7 p.Arg560Thr details
* 31 mutations: F508del, I507del,
Q493X
,
V520F
, 1717y1GࡊA,
G542X
,
G551D
,
R553X
,
R560T
,
S549R
, S549 N, 3849q10kbCࡊT, 3849q ** 4AࡊG,
R1162X
, 3659delC,
W1282X
, 3905insT, 621q1GࡊT,
R117H
,
Y122X
, 711q1GࡊT, 1078delT,
R347P
,
R347H
, R334 W,
A455E
,
N1303K
,
G85E
, 1898q1GࡊA, 2183AAࡊG, 2789q5GࡊA. that the laboratory criteria for the diagnosis of CF should be expanded to include identification of CFTR mutations and abnormal bioelectrical properties of the nasal epithelium, in addition to the sweat test w7x.
Login to comment
135
ABCC7 p.Gly551Ser
X
ABCC7 p.Gly551Ser 15463882:135:147
status:
NEW
view ABCC7 p.Gly551Ser details
However, it is now clear that some CF mutations are associated with normal sweat chloride values, as described for the 3849q10kbCࡊT w22x and
G551S
mutations w23x.
Login to comment
141
ABCC7 p.Ser1235Arg
X
ABCC7 p.Ser1235Arg 15463882:141:4
status:
NEW
view ABCC7 p.Ser1235Arg details
The
S1235R
mutation was also found in one of our patients who had a negative sweat test, but chronic bronchial colonization with P. aeruginosa and obstructive azoospermia.
Login to comment
142
ABCC7 p.Ser1235Arg
X
ABCC7 p.Ser1235Arg 15463882:142:36
status:
NEW
view ABCC7 p.Ser1235Arg details
Monaghan et al. w26x suggested that
S1235R
is pathogenic when combined with a second CF mutation, although phenotypic manifestations appear to be variable.
Login to comment
148
ABCC7 p.Gly542*
X
ABCC7 p.Gly542* 15463882:148:54
status:
NEW
view ABCC7 p.Gly542* details
The F508del mutation was found in 31 patients and the
G542X
mutation was found in five patients.
Login to comment
149
ABCC7 p.Ala455Glu
X
ABCC7 p.Ala455Glu 15463882:149:96
status:
NEW
view ABCC7 p.Ala455Glu details
The next most frequent mutations were the 2183AAࡊG, 3849q10kbCࡊT, 3272y26AࡊG,
A455E
and 2789q5GࡊA mutations, which were all found in at least three patients.
Login to comment
150
ABCC7 p.Ala455Glu
X
ABCC7 p.Ala455Glu 15463882:150:36
status:
NEW
view ABCC7 p.Ala455Glu details
The 3849q10kbCࡊT, 3272y26A)G,
A455E
and 2789q 5GࡊA mutations belong to the class V of CFTR mutations, which result in residual levels of CFTR transcripts and protein w17,24x.
Login to comment
151
ABCC7 p.Ala455Glu
X
ABCC7 p.Ala455Glu 15463882:151:4
status:
NEW
view ABCC7 p.Ala455Glu details
The
A455E
missense mutation is associated with mild lung disease w27x, whereas the 3272y26AࡊG w28x, 2789q5GࡊA w29x and 3849q10kbCࡊT w22x mutations are associated with a milder CF phenotype.
Login to comment